These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25203595)

  • 1. Association between chemokine receptor 5 delta32 polymorphism and susceptibility to cancer: a meta-analysis.
    Lee YH; Song GG
    J Recept Signal Transduct Res; 2015; 35(6):509-15. PubMed ID: 25203595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC; Song GG
    Mod Rheumatol; 2013 Mar; 23(2):304-10. PubMed ID: 22638733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility.
    Srivastava A; Pandey SN; Choudhuri G; Mittal B
    Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
    Song GG; Lee YH
    Immunol Invest; 2014; 43(4):299-311. PubMed ID: 24295368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: a large case-control study and meta-analysis.
    Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
    Autoimmunity; 2014 Sep; 47(6):383-8. PubMed ID: 24720467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine receptor 5 Δ32 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren's syndrome. Meta-analysis of possible associations.
    Lee YH; Kim JH; Song GG
    Z Rheumatol; 2014 Nov; 73(9):848-55. PubMed ID: 24599359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5-Delta32 polymorphism and susceptibility to cervical cancer: association with early stage of cervical cancer.
    Singh H; Sachan R; Jain M; Mittal B
    Oncol Res; 2008; 17(2):87-91. PubMed ID: 18543610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine receptor 5 delta32 polymorphism and type 1 diabetes, Behcet's disease, and asthma: a meta-analysis.
    Song GG; Kim JH; Lee YH
    Immunol Invest; 2014; 43(2):123-36. PubMed ID: 24171669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
    Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
    Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between chemokine receptor 5 Δ32/W gene polymorphism and lupus nephritis.
    Zhou TB; Jiang ZP; Zhou JF; Su N
    Hum Immunol; 2014 Sep; 75(9):968-72. PubMed ID: 25167769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
    Sandford B; Bown M; London N; Sayers R
    Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
    Prahalad S
    Genes Immun; 2006 Apr; 7(3):264-8. PubMed ID: 16541097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects.
    Ying H; Wang J; Gao X
    Tumour Biol; 2014 Jun; 35(6):5895-904. PubMed ID: 24687549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CCR5-Δ32 heterozygosity on HIV-1 susceptibility: a meta-analysis.
    Liu S; Kong C; Wu J; Ying H; Zhu H
    PLoS One; 2012; 7(4):e35020. PubMed ID: 22496885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of chemokines receptor (CCR5 Delta32) in idiopathic recurrent miscarriages among north Indians.
    Parveen F; Tripathi G; Singh B; Agrawal S
    Arch Gynecol Obstet; 2009 Aug; 280(2):229-34. PubMed ID: 19116725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CC chemokine receptor 5 Δ32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan.
    Sophie M; Hameed A; Muneer A; Samdani AJ; Saleem S; Azhar A
    J Cutan Pathol; 2016 Jul; 43(7):564-70. PubMed ID: 26970327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
    Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
    DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5-Δ32 polymorphism is a genetic risk factor associated with dyslipidemia in patients with type 1 diabetes.
    Słomiński B; Ławrynowicz U; Ryba-Stanisławowska M; Skrzypkowska M; Myśliwska J; Myśliwiec M
    Cytokine; 2019 Feb; 114():81-85. PubMed ID: 30420202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common CCR 5 polymorphism in stroke: the CCR 5 delta32 polymorphism differentiates cardioembolism from other aetiologies of ischaemic cerebrovascular diseases.
    Kostulas N; Markaki I; Kostulas V; Hillert J; Kostulas K
    Scand J Immunol; 2009 Nov; 70(5):475-80. PubMed ID: 19874552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.